Clinical Trials in Denver

Showing 10661-10680 of 18,161 trials

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

NCT00833326

This is a Phase 1 study during which patients with advanced/metastatic solid tumors will receive investigational study drug ARRY-334543 and docetaxel (with prophylactic growth factor support). Patients will receive increasing doses of study drug in combination with docetaxel in order to achieve the highest dose of study drug possible that will not cause unacceptable side effects. Patients will be followed to see what side effects the combination causes and what effectiveness the combination has, if any, in treating the cancer. Approximately 30 patients from the US will be enrolled in this study.

Advanced Cancer

Array Biopharma, now a wholly owned subsidiary of Pfizer27 participantsStarted Jan 2009

Aurora, Colorado, United States • Rochester, Minnesota, United States • Nashville, Tennessee, United States

UNKNOWN8.4 miles

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

NCT04566055

Prospective Observational Multicenter Cohort. External validation of donor derived cell free DNA in Renal Transplantation. Assessing performance of dd-cfDNA as a surveillance tool and its association with clinical outcomes. Outcomes include formation of de-novo DSA, eGFR decline, performance of AlloSure dd-cfDNA in Allograft rejection.

Kidney Transplant Rejection

CareDx1,000 participantsStarted Mar 2019

Aurora, Colorado, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +5 more locations

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

Find Trials by Condition in Denver

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis

Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Single Arm on the Tolerability of Weekly Nab-paclitaxel

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

Confirmation of Ventilation and Intubation by Determination With Ultrasonography

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study